BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22258352)

  • 21. Hypercalcaemia in relapsed medulloblastoma 8 years post-diagnosis; evidence to support PTHrP production by medulloblastoma cells.
    Dharmaraj P; Ball S; Johnstone H; Bailey S; Clifford SC; Hale J; Cheetham TD
    Horm Res; 2006; 66(6):268-72. PubMed ID: 16946619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of an extraneural metastasized medulloblastoma].
    Huber A; Bohl J; Gutjahr P
    Klin Padiatr; 1990; 202(3):186-7. PubMed ID: 2355723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Medulloblastoma with mandibular metastasis after complete remission of the central nervous system lesions].
    Yoshimura J; Nishiyama K; Takahashi H; Mori H; Tanaka R; Umezu H
    No To Shinkei; 2005 Jan; 57(1):37-40. PubMed ID: 15782598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zoledronic acid in the treatment of bone metastases by hepatocellular carcinoma: a case series.
    Montella L; Addeo R; Palmieri G; Caraglia M; Cennamo G; Vincenzi B; Guarrasi R; Mamone R; Faiola V; Frega N; Capasso E; Maiorino L; Leopardo D; Pizza C; Montesarchio V; Del Prete S
    Cancer Chemother Pharmacol; 2010 May; 65(6):1137-43. PubMed ID: 19760218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic factors after extraneural metastasis of medulloblastoma.
    Mazloom A; Zangeneh AH; Paulino AC
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):72-8. PubMed ID: 20133080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medulloblastoma in the second decade of life: a specific group with respect to toxicity and management: a Canadian Pediatric Brain Tumor Consortium Study.
    Tabori U; Sung L; Hukin J; Laperriere N; Crooks B; Carret AS; Silva M; Odame I; Mpofu C; Strother D; Wilson B; Samson Y; Bouffet E;
    Cancer; 2005 May; 103(9):1874-80. PubMed ID: 15770645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biomarker alterations with metronomic use of low-dose zoledronic acid for breast cancer patients with bone metastases and potential clinical significance.
    Zhao X; Xu X; Guo L; Ragaz J; Guo H; Wu J; Shao Z; Zhu J; Guo X; Chen J; Zhu B; Wang Z; Hu X
    Breast Cancer Res Treat; 2010 Dec; 124(3):733-43. PubMed ID: 20882405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extraneural metastases from cerebellar medulloblastoma.
    Lowery GS; Kimball JC; Patterson RB; Raben M
    Am J Pediatr Hematol Oncol; 1982; 4(3):259-62. PubMed ID: 7149167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effect of doxorubicin and zoledronic acid on intraosseous versus extraosseous breast tumor growth in vivo.
    Ottewell PD; Deux B; Mönkkönen H; Cross S; Coleman RE; Clezardin P; Holen I
    Clin Cancer Res; 2008 Jul; 14(14):4658-66. PubMed ID: 18628481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined therapy of Sr-89 and zoledronic acid in patients with painful bone metastases.
    Storto G; Klain M; Paone G; Liuzzi R; Molino L; Marinelli A; Soricelli A; Pace L; Salvatore M
    Bone; 2006 Jul; 39(1):35-41. PubMed ID: 16434248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of site of tumor recurrence upon survival for children with recurrent or progressive medulloblastoma.
    Bowers DC; Gargan L; Weprin BE; Mulne AF; Elterman RD; Munoz L; Giller CA; Winick NJ
    J Neurosurg; 2007 Jul; 107(1 Suppl):5-10. PubMed ID: 17644914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A phase I dose-ranging trial of monthly infusions of zoledronic acid for the treatment of osteolytic bone metastases.
    Berenson JR; Vescio RA; Rosen LS; VonTeichert JM; Woo M; Swift R; Savage A; Givant E; Hupkes M; Harvey H; Lipton A
    Clin Cancer Res; 2001 Mar; 7(3):478-85. PubMed ID: 11297237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiotherapy and adjuvant chemotherapy for childhood medulloblastoma. The Royal Marsden Hospital experience.
    Whitton AC; Syndikus I; Tait DM; Bloom HJ
    Strahlenther Onkol; 1995 Nov; 171(11):615-21. PubMed ID: 7502224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymph node metastasis in medulloblastoma.
    Sheikh B; Kanaan I
    Pediatr Neurosurg; 1994; 20(4):269-71. PubMed ID: 8043466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotherapy of medulloblastoma.
    Gajjar A; Kühl J; Epelman S; Bailey C; Allen J
    Childs Nerv Syst; 1999 Oct; 15(10):554-62. PubMed ID: 10550586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case of molecularly profiled extraneural medulloblastoma metastases in a child.
    Mobark NA; Al-Harbi M; Mosleh O; Santagata S; Snuderl M; Abedalthagafi M
    BMC Med Genet; 2018 Jan; 19(1):10. PubMed ID: 29343221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generalized osteoblastic bony metastases from medulloblastoma.
    Ho EP; Lieber A; DeLand FH; Maruyama Y
    Oncology; 1976; 33(5-6):253-6. PubMed ID: 1026858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemotherapeutic response in metastatic medulloblastoma: report of two cases and a review of the literature.
    Nathanson L; Kovacs SG
    Med Pediatr Oncol; 1978; 4(2):105-10. PubMed ID: 661749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MR imaging of skeletal metastases from medulloblastoma.
    Algra PR; Postma T; Van Groeningen CJ; Van der Valk P; Bloem JL; Valk J
    Skeletal Radiol; 1992; 21(7):425-30. PubMed ID: 1439892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extraneural Metastases From Desmoplastic Medulloblastoma Masquerading as Lymphoma.
    Mahajan A; Paul P; Sridhar E; Rangarajan V; Gupta T; Chinnaswamy G; Moiyadi A; Jalali R
    Clin Nucl Med; 2017 May; 42(5):354-357. PubMed ID: 28263211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.